Virax Biolabs Group Limited (VRAX)
NASDAQ: VRAX · Real-Time Price · USD
2.940
-0.320 (-9.82%)
At close: Jun 30, 2026, 4:00 PM EDT
2.980
+0.040 (1.36%)
After-hours: Jun 30, 2026, 7:49 PM EDT
Virax Biolabs Group Market Cap
Virax Biolabs Group has a market cap or net worth of $2.34 million as of June 30, 2026. Its market cap has decreased by -38.85% in one year.
Market Cap
2.34M
Enterprise Value
-285.90K
1-Year Change
-38.85%
Ranking
Category
Stock Price
$2.94
Market Cap Chart
Since the IPO on July 21, 2022, Virax Biolabs Group's market cap has decreased from $207.01M to $2.34M, a decrease of -98.87%. That is a compound annual growth rate of -67.89%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 30, 2026 | 2.34M | -8.73% |
| Dec 31, 2025 | 2.57M | -73.72% |
| Dec 31, 2024 | 9.77M | 269.38% |
| Dec 29, 2023 | 2.64M | -71.76% |
| Dec 30, 2022 | 9.36M | -95.48% |
| Jul 21, 2022 | 207.01M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Onconetix | 3.45M |
| Clearmind Medicine | 3.27M |
| Creative Medical Technology Holdings | 3.25M |
| GRI Bio | 3.22M |
| Calidi Biotherapeutics | 3.11M |
| SciSparc | 3.06M |
| VivoSim Labs | 2.95M |
| CDT Equity | 2.78M |